CoChat

RETRACTED ARTICLE: Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Polycystic ovarian syndrome (PCOS) induces anovulation in women of reproductive age, and is one of the pathological factors involved in the failure of in vitro fertilization (IVF). Indeed, PCOS women are characterized by poor quality oocytes. Therefore, a treatment for enhancing oocyte quality becomes crucial for these patients. Myo-Inositol and melatonin proved to be efficient predictors for positive IVF outcomes, correlating with high oocyte quality. We tested the synergistic effect of myo-inositol and melatonin in IVF protocols with PCOS patients in a randomized, controlled, double-blind trial. Five-hundred twenty-six PCOS women were divided into three groups: Controls (only folic acid: 400 mcg), Group A (Inofolic® plus, a daily dose of myo-inositol: 4000 mg, folic acid: 400 mcg, and melatonin: 3 mg), and Group B (Inofolic®, a daily dose of myo-inositol: 4000 mg, and folic acid: 400 mcg). The main outcome measures were oocyte and embryo quality, clinical pregnancy and implantation rates. The treatment lasted from the first day of the cycle until 14 days after embryo transfer. Myo-inositol and melatonin have shown to enhance, synergistically, oocyte and embryo quality. In consideration of the beneficial effect observed in our trial and on the bases of previous studies, we decided to integrate routinely MI and M supplementation in the IVF protocols. The same treatment should be taken carefully in consideration in all procedures of this kind.

Overview

Integrity signals

Registry

Crossref · 10.3109/09513590.2015.1101444This paper is marked retracted.

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

4 retracted

Show all 46 references

Cited by

See all 127

Metadata

Authors
Pacchiarotti, A., Carlomagno, G., Antonini, G., & Pacchiarotti, A.
Affiliations
  • Sapienza University of Rome (IT)
  • Farmares SRL
Corresponding author
Pacchiarotti, Arianna
Venue
Gynecological Endocrinology
Published
2015-10-28
Volume
32
Issue
1
Pages
69-73
ISSN
  • 0951-3590 (ISSN-L)
  • 1473-0766
OpenAlex
W1844254983
Cited by
111
References
46
Citations by year
2026: 6 · 2025: 16 · 2024: 18 · 2023: 8 · 2022: 9 · 2021: 15 · 2020: 8 · 2019: 7 · 2018: 8 · 2017: 8 · 2016: 7
FWCI
8.74
Type
journal article
Language
en
Status
Retracted
Open access
closed
Locations
  • Gynecological Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
Keywords
myo-inositol, melatonin, polycystic ovary syndrome, in vitro fertilization, oocyte quality, embryo quality, clinical pregnancy rate, implantation rate, folic acid supplementation, synergistic supplementation, retracted article
MeSH terms
Adult, Antioxidants, Double-Blind Method, Drug Therapy, Combination, Embryo Transfer, Female, Fertilization in Vitro, Folic Acid, Humans, Infertility, Female, Inositol, Melatonin, Oocytes, Polycystic Ovary Syndrome, Pregnancy, Vitamin B Complex, Treatment Outcome, Pregnancy Rate, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RETRACTED ARTICLE: Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. https://app.cochat.ai/papers/10.3109/09513590.2015.1101444
The paper
Pacchiarotti, A., Carlomagno, G., Antonini, G., & Pacchiarotti, A. (2016). RETRACTED ARTICLE: Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. Gynecological Endocrinology. https://doi.org/10.3109/09513590.2015.1101444

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.